The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.

Bruno Watschinger; Hermann Salmhofer; Sabine Horn; Ulrich Neyer; Tatjana Wiesinger; Martin Wiesholzer; Helmut Erb; Christine Jaeger; Margit Hemetsberger; Alexander R Rosenkranz

doi:10.1007/s00508-012-0311-1

The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.

Bruno Watschinger, Hermann Salmhofer (Co-author), Sabine Horn, Ulrich Neyer, Tatjana Wiesinger, Martin Wiesholzer, Helmut Erb, Christine Jaeger, Margit Hemetsberger, Alexander R Rosenkranz

Department of Internal Medicine I- Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetologylog

Research output: Contribution to journal › Original Article › peer-review

3 Citations (Web of Science)

Original language	English
Pages (from-to)	71-82
Journal	WIENER KLINISCHE WOCHENSCHRIFT
Volume	125
Issue number	3-4
DOIs	https://doi.org/10.1007/s00508-012-0311-1
Publication status	Published - 2013

Keywords

CHRONIC KIDNEY-DISEASE
RECOMBINANT-HUMAN-ERYTHROPOIETIN
C-REACTIVE PROTEIN
HEMODIALYSIS-PATIENTS
LEVEL VARIABILITY
TARGET HEMOGLOBIN
EPOETIN-ALPHA
INTERCURRENT EVENTS
ANEMIA MANAGEMENT
FAILURE PATIENTS

Access to Document

10.1007/s00508-012-0311-1

Cite this

Watschinger, B., Salmhofer, H., Horn, S., Neyer, U., Wiesinger, T., Wiesholzer, M., Erb, H., Jaeger, C., Hemetsberger, M., & Rosenkranz, A. R. (2013). The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin. WIENER KLINISCHE WOCHENSCHRIFT, 125(3-4), 71-82. https://doi.org/10.1007/s00508-012-0311-1

@article{898f8f4d4305486ba456d3fe9e7e576f,

title = "The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.",

keywords = "CHRONIC KIDNEY-DISEASE, RECOMBINANT-HUMAN-ERYTHROPOIETIN, C-REACTIVE PROTEIN, HEMODIALYSIS-PATIENTS, LEVEL VARIABILITY, TARGET HEMOGLOBIN, EPOETIN-ALPHA, INTERCURRENT EVENTS, ANEMIA MANAGEMENT, FAILURE PATIENTS",

author = "Bruno Watschinger and Hermann Salmhofer and Sabine Horn and Ulrich Neyer and Tatjana Wiesinger and Martin Wiesholzer and Helmut Erb and Christine Jaeger and Margit Hemetsberger and Rosenkranz, {Alexander R}",

note = "H. Salmhofer, MD Department of Internal Medicine I, Paracelsus Medical University of Salzburg, Salzburg, Austria",

year = "2013",

doi = "10.1007/s00508-012-0311-1",

language = "English",

volume = "125",

pages = "71--82",

journal = "WIENER KLINISCHE WOCHENSCHRIFT",

issn = "0043-5325",

publisher = "Springer Nature",

number = "3-4",

}

Watschinger, B, Salmhofer, H, Horn, S, Neyer, U, Wiesinger, T, Wiesholzer, M, Erb, H, Jaeger, C, Hemetsberger, M & Rosenkranz, AR 2013, 'The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.', WIENER KLINISCHE WOCHENSCHRIFT, vol. 125, no. 3-4, pp. 71-82. https://doi.org/10.1007/s00508-012-0311-1

TY - JOUR

T1 - The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.

AU - Watschinger, Bruno

AU - Salmhofer, Hermann

AU - Horn, Sabine

AU - Neyer, Ulrich

AU - Wiesinger, Tatjana

AU - Wiesholzer, Martin

AU - Erb, Helmut

AU - Jaeger, Christine

AU - Hemetsberger, Margit

AU - Rosenkranz, Alexander R

N1 - H. Salmhofer, MD Department of Internal Medicine I, Paracelsus Medical University of Salzburg, Salzburg, Austria

PY - 2013

Y1 - 2013

KW - CHRONIC KIDNEY-DISEASE

KW - RECOMBINANT-HUMAN-ERYTHROPOIETIN

KW - C-REACTIVE PROTEIN

KW - HEMODIALYSIS-PATIENTS

KW - LEVEL VARIABILITY

KW - TARGET HEMOGLOBIN

KW - EPOETIN-ALPHA

KW - INTERCURRENT EVENTS

KW - ANEMIA MANAGEMENT

KW - FAILURE PATIENTS

U2 - 10.1007/s00508-012-0311-1

DO - 10.1007/s00508-012-0311-1

M3 - Original Article

C2 - 23299452

SN - 0043-5325

VL - 125

SP - 71

EP - 82

JO - WIENER KLINISCHE WOCHENSCHRIFT

JF - WIENER KLINISCHE WOCHENSCHRIFT

IS - 3-4

ER -